Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -3.21% | -2.31% | -69.94% |
06:44pm | TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing | MT |
05-20 | TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.94% | 6.75M | |
+64.28% | 62.59B | |
-1.08% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.41% | 26.21B | |
-21.53% | 19.09B | |
+4.91% | 13.08B | |
+25.72% | 12.26B | |
+28.81% | 12.05B |
- Stock Market
- Equities
- TFFP Stock
- News TFF Pharmaceuticals, Inc.
- B. Riley Lowers TFF Pharmaceuticals' Price Target to $18 from $24 Mainly to Reflect Delays Noted with Select Pipeline, Corporate Milestones; Keeps Buy Rating